0001562180-21-007146.txt : 20211117
0001562180-21-007146.hdr.sgml : 20211117
20211117211615
ACCESSION NUMBER: 0001562180-21-007146
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211115
FILED AS OF DATE: 20211117
DATE AS OF CHANGE: 20211117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Woock John
CENTRAL INDEX KEY: 0001756437
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38721
FILM NUMBER: 211422410
MAIL ADDRESS:
STREET 1: 26 TECHNOLOGY DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Axonics, Inc.
CENTRAL INDEX KEY: 0001603756
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 454744083
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 26 TECHNOLOGY DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-396-6322
MAIL ADDRESS:
STREET 1: 26 TECHNOLOGY DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92618
FORMER COMPANY:
FORMER CONFORMED NAME: Axonics Modulation Technologies, Inc.
DATE OF NAME CHANGE: 20140326
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2021-11-15
false
0001603756
Axonics, Inc.
AXNX
0001756437
Woock John
26 TECHNOLOGY DRIVE
IRVINE
CA
92618
false
true
false
false
Chief Marketing Officer
Common Stock
2021-11-15
4
M
false
5000.00
14.19
A
29932.00
D
Common Stock
2021-11-15
4
S
false
2016.00
60.1235
D
27916.00
D
Common Stock
2021-11-15
4
S
false
2984.00
60.7279
D
24932.00
D
Stock Option (Right to Buy)
14.19
2021-11-15
4
M
false
5000.00
0.00
D
2029-01-30
Common Stock
5000.00
30555.00
D
This sale was pursuant to a 10b5-1 plan adopted by the reporting person on June 15, 2021.
This transaction was executed in multiple trades at prices ranging from $59.54 to $60.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $60.57 to $60.835. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on January 30, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on January 30, 2023, provided the reporting person remains in continuous service on each vesting date.
/s/ Dan Dearen, as Attorney-in-Fact for John Woock, Ph.D
2021-11-17